<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01390766</url>
  </required_header>
  <id_info>
    <org_study_id>112305</org_study_id>
    <nct_id>NCT01390766</nct_id>
  </id_info>
  <brief_title>Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)</brief_title>
  <official_title>Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This post-marketing surveillance (PMS) study is designed to investigate the efficacy and
      safety of azathioprine tablets in Japanese subjects whom liver transplantation is performed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2002</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The number of incidence of adverse events related to azathioprine tablets and serious adverse events</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">41</enrollment>
  <condition>Liver Diseases</condition>
  <arm_group>
    <arm_group_label>Subjects prescribed azathioprine tablet</arm_group_label>
    <description>Subjects prescribed azathioprine tablet during study period after the liver transplantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Azathioprine</intervention_name>
    <arm_group_label>Subjects prescribed azathioprine tablet</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The following subjects to whom azathioprine tablet is administered for &quot;the suppression of
        liver transplant rejection&quot;;

          -  Subjects on whom liver transplantation is performed and to whom azathioprine tablet is
             administered within 1 year after transplant surgery from the approval date of the
             additional indication of azathioprine tablet for liver transplantation (20 June 2001)
             to May 2010.

          -  Subjects on whom liver transplantation is performed before the approval date of the
             additional indication of azathioprine tablet for liver transplantation (20 June 2001)
             and to whom azathioprine tablet is administered within 1 year after transplant
             surgery.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who undergo liver transplantation and azathioprine tablet was administered

        Exclusion Criteria:

        As this is PMS study, there are no exclusion criteria but contraindications are as follows.

          -  Subjects with hypersensitivity to the ingredients of azathioprine tablet

          -  Subjects who is pregnant or might be pregnant

          -  Subjects whose white count is lower than 3000/cubic millimeter
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2011</study_first_submitted>
  <study_first_submitted_qc>July 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2011</study_first_posted>
  <last_update_submitted>August 30, 2012</last_update_submitted>
  <last_update_submitted_qc>August 30, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 3, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Antirejection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Azathioprine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

